Assessment of severity and mortality of COVID-19 with anti-A1 and anti-B IgM isohaemagglutinins, a reflection of the innate immune status.
Fatih OzcelikAlpaslan TanoğluBulent Barıs GuvenUmran KeskinMustafa KaplanPublished in: International journal of clinical practice (2021)
Anti-B and anti-A1 isohaemagglutinins, which are an expression of the innate immune system, can be used to predict the severity and mortality of COVID-19 disease.